Skip to main content
. 2014 May 20;26(3):255–273. doi: 10.1007/s12640-014-9477-9

Fig. 1.

Fig. 1

Microphotographs from MAP-2 immunofluorescence of 7DIV mouse primary cortical neurons treated with celastrol (Cel, 1 μM) and lactacystin (Lac, 2.5 μg/ml) for 48 h (a, d, e, and f). Celastrol enhanced the reduction in the number of MAP-2 positive cells in lactacystin-treated primary neuronal cell cultures. The purity of neuronal cell cultures (about 90 % neurons) was confirmed by double-immunostainig of vehicle-treated cells with neuronal (anti-MAP-2) and glia (anti-GFAP) specific markers (a, b, and c)